Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$23.64 - $30.27 $1,725 - $2,209
-73 Reduced 15.18%
408 $11,000
Q3 2023

Nov 13, 2023

BUY
$26.74 - $40.81 $481 - $734
18 Added 3.89%
481 $12,000
Q2 2023

Dec 12, 2023

SELL
$28.52 - $40.7 $513 - $732
-18 Reduced 3.74%
463 $17,000
Q2 2023

Aug 08, 2023

SELL
$28.52 - $40.7 $3,507 - $5,006
-123 Reduced 20.99%
463 $17,000
Q1 2023

Dec 12, 2023

BUY
$29.39 - $36.27 $3,085 - $3,808
105 Added 21.83%
586 $18,000
Q1 2023

May 01, 2023

BUY
$29.39 - $36.27 $17,222 - $21,254
586 New
586 $0

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.